StockData
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. (AVR) stock

AVRNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$5.32−0.38 (-6.67%)

Close on Nov 17, 2026Market cap $518.48MP/E –Yield –

Anteris Technologies Global r&d expenses

Research and development expenses are spending on new products and technology.

Anteris Technologies Global's R&D Expenses for the twelve months ending Sep 30, 2026 was $81.67M, up 29.8% year over year. For fiscal 2025 it was $69.12M, up 34.3% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$69.12M+34.3%
FY2024Dec 31, 2024$51.45M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$21.33M+26.9%
Q2 FY2026Jun 30, 2026$23.37M+43.0%
Q1 FY2026Mar 31, 2026$17.46M+6.1%
Q4 FY2025Dec 31, 2025$19.51M+46.5%
Q3 FY2025Sep 30, 2025$16.81M+20.5%
Q2 FY2025Jun 30, 2025$16.34M+29.3%
Q1 FY2025Mar 31, 2025$16.46M+42.4%
Q4 FY2024Dec 31, 2024$13.32M–
Q3 FY2024Sep 30, 2024$13.95M–
Q2 FY2024Jun 30, 2024$12.63M–
Q1 FY2024Mar 31, 2024$11.56M–

More Anteris Technologies Global figures

See a number that looks wrong?